Correlations between Extranodal Metastasis and Prognosis in Patients with Squamous Cell Carcinoma of the Esophagus by OTSUKA Koji et al.
Showa Univ J Med Sci 24（3）, 219～229, September 2012
Correlations between Extranodal Metastasis and Prognosis in Patients  
with Squamous Cell Carcinoma of the Esophagus
Koji OTSUKA, Masahiko MURAKAMI, Yusuke TAJIMA,  
Kimiyasu YAMAZAKI, Satoru GOTOH and Tetsuo SAWATANI
Abstract : Background  Extranodal metastasis （EM） has been reported in car-
cinomas of many organs.  However, the clinicopathological signicance of EM 
in squamous cell carcinoma of the esophagus remains unclear, and this study 
sought to clarify this issue.  Methods  This study included 220 patients who 
underwent an esophagectomy with lymphadenectomy for primary esophageal 
carcinoma from 1996 to 2008.  EM was defined as the presence of cancer 
cells in the soft tissue that were discontinuous with the primary lesion, or in 
the perinodal soft tissue distinct from the lymph nodes.  Results  EM was 
detected in 25 （9.6％） of the 220 patients, and in 56 （0.7％） of the 8,186 nod-
ules retrieved as ‘lymph nodes’.  The incidence of EM was signicantly higher 
in patients who had tumors of a larger size （diameter ≥ 4 cm）, lymphatic 
vessel invasion, lymph node metastasis, a high pathological stage, infiltrative 
growth pattern, or a high pT-stage.  The 5-year overall survival rates in N0-1 
patients with EM were significantly lower than in the patients without EM 
（P＝ 0.005）.  Conclusion  EM is closely associated with the development and 
aggressiveness of esophageal carcinoma, and the presence of EM can be useful 
for predicting prognosis after surgery in N0-1esophageal carcinoma patients.
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Introduction
　Lymph node metastasis is a form of tumor spreading that is recognized as an important 
prognostic factor in several types of cancers, including squamous cell carcinoma of the 
esophagus.  However, the spread of cancer cells to extracapsular connective tissues sur-
rounding the lymph nodes, called extranodal metastasis （EM）1-3）, is also often found during 
detailed histological investigations of resected lymph nodes in squamous cell carcinoma of 
the esophagus.  EM has also been reported in carcinomas of the stomach 4-7）, rectum 8, 9）, 
thyroid 10, 11）, breast 12, 13）, vulva 14）, and lung 15, 16）, and such metastasis has been linked to the 
rate of disease progression.  However, few studies have examined the impact of EM on 
prognosis in patients with squamous cell carcinoma of the esophagus 2, 17）, prompting this 
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study aimed at clarifying the clinicopathological signicance of EM in this patient group.
Materials and Methods
　Two hundred and twenty patients with thoracic esophageal cancer were admitted to 
Showa University Hospital from November 1996 to May 2008 ; all of these underwent 
video-assisted thoracoscopic surgery for esophageal cancer （VATS-E）.  Ninety-three patients 
underwent VATS-E with en bloc lymphadenectomy of cervical, mediastinal, and abdominal 
lymph nodes （three-eld lymphadenectomy）.  The remaining 131 patients underwent VATS-
E with en bloc lymphadenectomy of the mediastinal and abdominal lymph nodes （two-eld 
lymphadenectomy）.  The criteria for three-eld lymphadenectomy included patients without 
serious systemic disease, localization of the tumor to the upper thoracic esophagus, and 
other localizations with metastasis of recurrent nerve lymph nodes detected by intraoperative 
histopathological examination.  The median follow-up period after resection ranged from 1.5 
to 153 months （median : 32.4 months）.
　Immediately after surgery, a surgeon separated the excised specimens, which comprised the 
esophagus, gastric fundus, and surrounding soft tissues including lymph nodes dissected en 
bloc.  The isolated lymph nodes, which contained some of the surrounding fat tissue, were 
grouped according to the Guidelines for the Clinical and Pathological Studies of Carcinoma 
of the Esophagus （10 th edition）18）.  The number of dissected lymph nodes ranged from 7 
to 169 （median 39.2） per patient, and a total of 8,186 lymph nodes were examined in the 
present study.  All resected specimens were xed in 10％ formalin, embedded in parafn, 
and stained with hematoxylin and eosin.  All solid structures in adipose connective tissue 
resected with the esophagus were retrieved, including the lymph nodes and any areas of 
extranodal metastasis （EM）.  In this study, EM was dened as the presence of cancer cells 
in soft tissue that was discontinuous with the primary lesion, or in perinodal soft tissue dis-
tinct from the lymph nodes.  The clinicopathological features of the tumors are summarized 
in Table 1.
Statistical analysis
　The correlation between EM and clinicopathological features was determined using a 
Fisher’s exact test, χ2 test or Mann-Whitney U test.  The cumulative overall and disease-
free survival rates were calculated using the Kaplan-Meier method and compared using the 
log rank test.  A multivariate analysis was performed using the Cox proportional hazard 
model together with factors described previously.  A P-value of ＜ 0.05 was considered to be 
signicant.
Results
　EM was detected in 25 （9.6％） of the 220 patients and in 56 （0.7％） of the 8,186 nod-
ules retrieved as ‘lymph nodes’ （Fig. 1）.  We investigated the clinicopathological factors of 
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186 patients after surgery except for patients who died of causes unrelated to esophageal 
cancer.  Of these 25 patients with EM, 24 （96.0％） were histopathologically diagnosed as 
being positive for lymph node metastasis.
　We found no significant differences in sex, tumor location, venous invasion, intramural 
metastasis, or histopathological type between the EM-positive group and EM-negative groups. 
Table 1.  Patient demographics and tumor characteristics
Variable No. of patients
Age ;  years, mean（range） 65 （42-87）
Gender
Male 193
Female  27
Tumor location
Cervical esophagus   3
Upper thoracic   31
Middle thoracic 106
Lower thoracic  71
Abdominal esophagus  10
Depth of tumor invasion
T0  13
T1  59
T2  39
T3 102
T4   7
Lymphatic vessel invasion
Negative  81
Positive 139
Venous invasion
Negative  91
Positive 129
Intramural metastasia
Negative 178
Positive  42
Lymph node metastasis
N0-1 132
N2-4  88
Number of metastatic nodes
No nodal metastasis 100
1-3 lymph nodes  67
4 or more lymph nodes  53
Clinical and pathological characteristics were grouped 
according to the guidelines for the clinical and pathological 
studies of carcinoma of the esophagus （10th edition）
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However, a univariate analysis of the clinicopathological features showed that the incidence 
of EM was signicantly higher in patients with the following : lesions more than 40 mm 
in diameter, lesions with lymphatic vessel invasion, lymph node metastasis, lesions with a 
larger number of lymph node metastases, lesions with higher pathological stage, and lesions 
with an inltrative growth pattern.  Furthermore, the incidence of EM was also signicantly 
higher in patients with pT3-pT4 tumors than in those with pT0-pT2 tumors （Table 2）.
　The Kaplan-Meier survival curves of the estimated overall survival and disease-free 
survival are shown in Figures 2 and 3.  The 5-year overall survival rates were signicantly 
lower in patients with EM than in patients without EM at 15.7％ and 52.9％, respectively. 
Similarly, the 5-year disease-free survival rate in patients with EM was 20％ compared to 
50.3％ in patients without EM.
　Multivariate analyses revealed that tumor location, depth of tumor invasion, intramural 
metastasis, and pathological stage were statistically signicant, independent factors inuencing 
the overall survival and disease-free survival in the present series （Tables 3, 4）, while lymph 
node metastasis was not identied as an independent prognostic factor in the present study. 
However, it is known that lymph node metastasis worsens the prognosis in esophageal 
cancer 19-21）.  Thus, to eliminate this as a factor from our analysis, we divided the patients 
into two groups according to levels of lymph node metastasis （N0-1 vs. N2-4）, and then re-
analyzed the estimated overall survival and disease-free survival （Fig. 4a, b）.  The 5-year 
overall survival rates in N0-1 patients with EM were still signicantly lower than in N0-1 
patients without EM （Fig. 4a）; however, the 5-year overall survival rates in N2-4 patients 
with EM were not signicantly different from those in N2-4 patients without EM （P ＝
0.4384） （Fig. 4b）.  These results suggested that EM inuences the prognosis in N0-1 lymph 
node metastasis.  The 5-year disease-free survival rates with or without EM showed no 
signicant difference between N0-1 （P＝ 0.686） and N2-4 patients （P＝ 0.165） （Fig 5a, 5b）.
　Table 5 lists the sites of recurrence after surgery in patients with squamous cell carcinoma 
Fig. 1.  Hematoxylin and eosin staining shows extranodal metastasis in squamous cell carcinoma of the 
esophagus. Tumor cells are scattered in the perinodal soft tissue （a） and lymphatic vessels （b） 
are distinct from the metastatic lymph node. Original magnication a ×100, b ×200
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Table 2.  Relationship between clinicopathological factors and EM in 186 patients with 
squamous cell carcinoma of the esophagus
Variable No. of patients
EM Negative
n＝ 161
EM Positive
n＝ 25
P＝ value
Age ; years, mean 65.0 64.5
Gender
Male 140 20
Female 21 5 not signicant
Tumor size （cm）
＜ 4cm 87 7
≥ 4cm 74 18 P＝ 0.0154
Tumor location
Upper thoracic 28 2
Middle thoracic 73 14
Lower thoracic 60 9 not signicant
Depth of tumor invasion
pT0-pT2 77 6
pT3-pT4 84 19 P＝ 0.0272
Lymphatic vessel invasion
Negative 64 3
Positive 97 22 P＝ 0.0066
Venous invasion
Negative 73 8
Positive 88 17 not signicant
Intramural metastasis
Negative 146 20
Positive 15 5 not signicant
Lymph node metastasis
N0-1 102 7
N2-4 59 18 P＝ 0.0017
Number of metastatic nodes
No nodal metastasis 76 1
1-3 lymph nodes 49 10
4 or more lymph nodes 39 14 P＝ 0.0001
Stage
0 19 0
I 27 0
II 49 5
III 43 12
IVa 19 8
IVb 4 0 P＝ 0.003
Pathology
Well 39 6
Mod 92 15
Poor 23 1
Other 7 3 not signicant
Inltrative growth
a 46 3
b 111 19
c 4 3 P＝ 0.0222
Clinical and pathological characteristics were grouped according to the guidelines for 
the clinical and pathological studies of carcinoma of the esophagus （10th edition）
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of the esophagus.  The incidence of recurrence in the liver and recurrence in the lymph 
nodes was signicantly higher in patients with EM than in patients without EM.
Discussion
　EM can be identied by detailed histological examination of surgical specimens obtained 
by radical esophagectomy.  This distinctive type of tumor spread has also been reported in 
several types of carcinomas, and in this study, the incidence of EM among patients with 
esophageal carcinoma was 11.8％, which is similar to that reported previously 17）.  Non-resect-
ed cancer cells in the adipose connective tissue may be associated with tumor recurrence 
after surgery.  Therefore, a relatively high incidence of EM suggests that en bloc lymph 
Fig. 2.  Survival curves in patients with EM and those 
without EM
The 5-year overall survival rates were signicantly lower 
in patients with EM than in patients without EM （P ＝
0.0005）.
Fig. 3.  Disease-free intervals in patients with EM and 
those without EM
The 5-year disease-free survival rates were signicantly 
lower in patients with EM than in patients without EM 
（P＝ 0.0011）.
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Table 3.  Prognostic factors for the 5-year survival after surgery
Variable P＝ value HR 95％ CI
EM 0.2893 0.736 0.418-1.297
Age 0.5713 0.993 0.970-1.017
Gender 0.5371 1.202 0.667-2.175
Tumor location 0.0038 0.621 0.449-0.857
Tumor size 0.8366 0.952 0.600-1.513
Depth of tumor invasion 0.0139 2.057 1.158-3.654
Lymphatic vessel invasion 0.0685 1.289 0.981-1.693
Venous invasion 0.6598 1.062 0.813-1.386
Intramural metastasis 0.0185 2.070 1.130-3.792
Lymph node metastasis 0.722 0.892 0.475-1.676
Stage 0.0013 1.750 1.245-2.460
Inltrative growth
　　a 0.376 0.599 0.193-1.863
　　b 0.6915 0.808 0.281-2.319
Pathology 0.4868 1.111 0.826-1.495
Number of metastatic nodes 0.3483 0.819 0.540-1.243
HR : hazards ratio ; CI : condence intervals
Table 4.　Prognostic factors for a disease-free interval after surgery
Variable P＝ value HR 95％ CI
EM 0.2893 0.710 0.390-1.292
Age 0.2047 0.985 0.963-1.008
Gender 0.3777 1.301 0.725-2.337
Tumor location 0.0017 0.608 0.445-0.830
Tumor size 0.9427 0.984 0.630-1.536
Depth of tumor invasion 0.0374 1.833 1.036-3.245
Lymphatic vessel invasion 0.1141 1.246 0.948-1.637
Venous invasion 0.9326 0.989 0.765-1.278
Intramural metastasis 0.0021 2.520 1.399-4.536
Lymph node metastasis 0.723 1.129 0.577-2.209
Stage 0.0057 1.605 1.148-2.246
Inltrative growth
　　a 0.3958 0.618 0.204-1.877
　　b 0.8862 0.928 0.332-2.593
Pathology 0.0880 1.304 0.961-1.768
Number of metastatic nodes 0.6440 0.904 0.588-1.389
HR : hazards ratio ; CI : condence intervals
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Table 5.  Site of recurrence after surgery
EM Negative EM Positive P-value
Liver 6 5 p＝ 0.0013
Lung 16 4 p＝ 0.3627
Lymph nodes 50 13 p＝ 0.0395
Others 5 0 p＝ 0.3717
Fig. 4.
a : Survival curves in N0-1 patients with EM and those without EM
The 5-year overall survival rates were signicantly lower in N0-1 patients with EM than in patients without 
EM （P ＝ 0.005）.
b : Survival curves in N2-4 patients with EM and those without EM
The 5-year overall survival rates in N2-4 patients with or without EM showed no signicant difference （P ＝
0.4384）.
Fig. 5.
a : Disease-free intervals in N0-1 patients with EM and those without EM
The 5-year disease-free survival rates in N0-1 patients with or without EM showed no signicant difference 
（P＝ 0.686）.
b : Disease-free intervals in N2-4 patients with EM and those without EM
The 5-year disease-free survival rates in N2-4 patients with or without EM showed no signicant difference 
（P＝ 0.1646）.
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node dissection could be essential for improving the prognosis of patients with esophageal 
carcinoma.
　Tanabe et al 17） showed that EM in esophageal carcinoma was signicantly associated with 
the depth of tumor invasion, intramural metastasis, lymph node metastasis, and the number 
of metastatic nodes.  In this study, EM was signicantly associated with the depth of tumor 
invasion, tumor size, lymphatic vessel invasion, number of metastatic nodes, pathological 
stage, and growth pattern.  Together these results implicate EM in the development and 
aggressiveness of esophageal carcinoma.
　Burn 22） hypothesized that the phenomenon of lymphaticovenous communication, when a 
lymph vessel is obstructed, occurs when cancer cells metastasize to a lymph node or lymph 
vessel and obstruct the flow of lymphatic fluid.  He referred to the possibility of liver 
metastasis occurring via a lymphatic route.  Tanaka et al 23） also suggested a relationship 
between liver metastasis and lymphatic involvement in gastric carcinoma.  They reported 
that the lymphatic system was closely related to the establishment of liver metastasis ; in 
particular, they found that EM was a signicant risk factor for liver metastasis.  In our 
study, hematogenous （liver or lung） metastasis occurred in 9 out of the 26 cases with EM. 
On the other hand, lymph node metastasis was detected in 13 cases.  Therefore, EM was 
signicantly associated with both hematogenous metastasis and lymph node metastasis （Table 
5）.  These data support the hypothesis that EM may be related to lymphaticovenous com-
munication.
　In many types of cancer, EM is known to be a pathological factor contributing to poor 
prognosis.  Particularly in the cases of gastric cancer, close associations of EM with liver 
and peritoneal metastases have been reported 8, 23）.  For example, Baba et al 3） analyzed 131 
patients who underwent complete resection of esophageal cancer, and found that the 5-year 
survival rate for 33 patients without involved nodes or perinodal tissue extension was 59.7％, 
compared to 14.0％ for 43 patients with perinodal fat involvement （EM）, suggesting that the 
surgical cure of patients with EM is very difcult ; the present study reported similar rates 
in patients with and without EM.  Together, these data support the notion that a nding of 
EM indicates a poor prognosis.
　The disease-free survival rate was also signicantly lower in patients with EM than in 
patients without EM, a finding that could be directly related to the differences in the 
overall survival rate between the groups.  Although lymph node metastasis was not prognos-
tically signicant in this study, we know clinically that it is closely related to survival.  Thus, 
we classied the extent of lymph node metastasis （N0-1 and N2-4）, and concluded that 
EM is signicantly associated with the survival of N0-1, but not N2-4 patients.  Therefore, 
this study showed that EM could be useful for predicting the prognosis of N0-1 patients 
with esophageal carcinoma after surgery, and further suggests that adjuvant therapy such as 
aggressive chemotherapy or chemoradiotherapy might be required to decrease postoperative 
recurrence in these patients, even after R0 resection of esophageal cancer.
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　To clarify the impact of EM on patient prognosis, Tanabe et al 17） conducted a multivariate 
analysis in patients with esophageal carcinoma and found that EM was not a signicant 
independent prognostic factor, as observed in our study.  Instead, tumor location, depth of 
tumor invasion, presence of intramural metastasis, and pathological stage were identified 
as signicant independent prognostic factors.  The discrepancy between the uni- and multi-
variate analyses could be explained by the possibility that variables such as the depth of 
invasion, intramural metastasis, tumor stage, and tumor location might all negatively affect 
prognosis, working as intermediate variables in the multivariate analyses, and thus negating 
or ameliorating the effect of EM as a prognostic factor.
　In conclusion, this study provided important information that will help us to better 
understand EM.  Our results show that EM is closely associated with the development and 
aggressiveness of esophageal carcinoma in N0-1 patients, and that EM can be useful for 
predicting the prognosis of esophageal carcinoma patients after surgery.
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